Dario Paggiarino Insider Profile

4 Followers
Dario Paggiarino, Sr VP & Chief Dev. Officer at Apollo Endosurgery, holds 0.00 shares in Apollo Endosurgery (Ticker: APEN), holds 67.08K shares in EyePoint Pharmaceuticals (Ticker: EYPT). Most recently, Dario Paggiarino ― shares of Apollo Endosurgery on ― for an estimated value of ―.
tipranks
Dario Paggiarino

Dario Paggiarino
Apollo Endosurgery (APEN)
Sr VP & Chief Dev. Officer

Ranked #5,598 out of 99,218 Corporate Insiders

Profitable Transactions

100%
6 out of 6 Profitable Transactions

Average Return

+45.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$780K
100.00%
A breakdown of Dario Paggiarino's holdings

Insider Roles

EyePoint Pharmaceuticals
(EYPT)
CMO
Roles that Dario Paggiarino holds in companies

Most Profitable Insider Trade

Stock:
EyePoint Pharmaceuticals
(EYPT)
Rating:Informative Sell
Date:Jan 29, 2024 - Today
Return:+54.80%
The most profitable trade made by Dario Paggiarino

Dario Paggiarino's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
APEN
Apollo Endosurgery
$0.00
EyePoint Pharmaceuticals
Apr 02, 2024
CMO
Uninformative Buy
513.81K
$780.14K
List of latest transactions for each holding click on a transaction to see Dario Paggiarino's performance on stock

Dario Paggiarino insider profile FAQ

What is the percentage of profitable transactions made by Dario Paggiarino?
The percentage of profitable transactions made by Dario Paggiarino is 100%.
    What is the average return per transaction made by Dario Paggiarino?
    The average return per transaction made by Dario Paggiarino is 45.90%.
      What stocks does Dario Paggiarino hold?
      Dario Paggiarino holds: APEN, EYPT stocks.
        What was Dario Paggiarino’s latest transaction?
        Dario Paggiarino latest transaction was an Uninformative Buy of ―.
          What was Dario Paggiarino's most profitable transaction?
          Dario Paggiarino’s most profitable transaction was an Informative Sell of EYPT stock on January 29, 2024. The return on the trade was 54.80%.
            What is Dario Paggiarino's role in Apollo Endosurgery?
            Dario Paggiarino's role in Apollo Endosurgery is Sr VP & Chief Dev. Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.